Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Veradermics, Inc.(MANE) | 0 | 2,401,868 | +2,401,868 | 0 | 151,678 | 16.57% | +151,678 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 153,000 | 269,440 | 29.43% | +116,440 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 19,129 | 43,177 | 4.72% | +24,048 |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,514,929 | 0 | 37,754 | 58,477 | 6.39% | +20,723 |
| Design Therapeutics, Inc. | 6,526,476 | 6,526,476 | 0 | 61,218 | 69,442 | 7.59% | +8,223 |
| Oruka Therapeutics, Inc(ORKA) | 430,330 | 430,330 | 0 | 13,043 | 21,108 | 2.31% | +8,064 |
| Oculis Holding AG | 641,022 | 641,022 | 0 | 12,801 | 17,045 | 1.86% | +4,244 |
| Nkarta, Inc. | 3,333,333 | 3,333,333 | 0 | 6,167 | 7,033 | 0.77% | +867 |
| Ultragenyx Pharmaceutical Inc.(RARE) | 137,753 | 137,753 | 0 | 3,168 | 2,886 | 0.32% | -282 |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | 6,752 | 5,092 | 0.56% | -1,660 |
| CRISPR Therapeutics AG(CRSP) | 2,038,763 | 2,038,763 | 0 | 106,913 | 96,984 | 10.59% | -9,929 |
| Mineralys Therapeutics Inc.(MLYS) | 1,563,966 | 1,563,966 | 0 | 56,756 | 42,368 | 4.63% | -14,388 |
| ARS Pharmaceuticals, Inc. | 4,012,903 | 4,012,903 | 0 | 46,750 | 32,224 | 3.52% | -14,527 |
| Zenas BioPharma, Inc(ZBIO) | 5,037,854 | 5,037,854 | 0 | 182,924 | 98,490 | 10.76% | -84,434 |